Biognosys Blood Biomarker Discovery Solution
Swiss proteomics firm Biognosys has launched its next-generation blood biomarker discovery solution as a contract research service. The service searches the complete plasma proteome to quantify up to 3,000 of the most relevant proteins and measure tens of thousands of peptide-level data points to provide a deep understanding of key disease pathways, Biognosys said. It can be applied across all biological species and to any other biofluid, such as cerebrospinal fluid or urine. In addition to the biofluid biomarker discovery service, an improved tissue biomarker discovery service is available, offering a depth of 10,000 proteins, the company said. Both services are based on Biognosys' proprietary Hyper Reaction Monitoring technology and optimized Liquid Chromatography-Mass Spectrometry workflow.